AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kestra Medical Technologies, Ltd.

$22.85 -$1.54 (-6.31%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$23.57
Day Range
$22.43$24.38
Year Range
$17.34$30
Market Cap
1.34B
AVG Volume
337.86K
Trailing/Forward PE
-9.44/-
PEG ratio
0.92
Dividend Yield
-
Next Earnings Date
2026-09-14
Primary Exchange
NASDAQUS
Revenue (USD)
010M20M30M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q428.64M
26 Q324.55M
26 Q222.57M
26 Q119.37M
25 Q417.23M
25 Q315.09M
25 Q214.71M
25 Q112.78M
24 Q410.05M
24 Q38.28M
Net Income (USD)
-60M-40M-20M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q4-38.84M
26 Q3-34.17M
26 Q2-32.78M
26 Q1-25.83M
25 Q4-52.05M
25 Q3-21.51M
25 Q2-20.37M
25 Q1-19.88M
24 Q4-22.28M
24 Q3-21.62M
Operating Income (USD)
-60M-40M-20M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q4-39.34M
26 Q3-34.76M
26 Q2-31.75M
26 Q1-28.88M
25 Q4-48.21M
25 Q3-20.6M
25 Q2-19.13M
25 Q1-18.43M
24 Q4-20.35M
24 Q3-19.95M
EBITDA (USD)
-60M-40M-20M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q4-50.13M
26 Q3-30.26M
26 Q2-28.48M
26 Q1-21.85M
25 Q4-47.41M
25 Q3-18.07M
25 Q2-17.34M
25 Q1-16.07M
24 Q4-16.87M
24 Q3-16.59M
Cash Flows (USD)
-40M-30M-20M-10M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q4-28.38M
26 Q3-28.16M
26 Q2-25.61M
26 Q1-34.44M
25 Q4-31.74M
25 Q3-22.45M
25 Q2-22.45M
25 Q1-24.56M
24 Q4-19.15M
24 Q3-20.76M
EPS (USD)
-3-2-1024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS EPS (USD) by quarter
PeriodEPS (USD)
26 Q4-0.67
26 Q3-0.61
26 Q2-0.64
26 Q1-0.5
25 Q4-2.21
25 Q3-0.5
25 Q2-0.48
25 Q1-0.45
24 Q4-0.45
24 Q3-0.47
Expenses (USD)
020M40M60M80MR&DSG&ACapex24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q464.69M
26 Q357.47M
26 Q250.44M
26 Q145.9M
25 Q463.89M
25 Q331.64M
25 Q229.39M
25 Q129.69M
24 Q425.95M
24 Q325.79M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt22 Q124 Q425 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q4196.43M
26 Q3291.32M
26 Q2175.42M
26 Q1201.21M
25 Q4237.59M
25 Q354.35M
25 Q276.92M
24 Q48.25M
22 Q111.08M
Debt ratios
00.511.5225 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Debt ratios by quarter
PeriodDebt ratios
26 Q41.14
26 Q31.91
26 Q21.13
26 Q11.5
25 Q41.95
25 Q30.11
25 Q20.46
Margins
0%20%40%60%24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Margins by quarter
PeriodMargins
26 Q454.76%
26 Q352.57%
26 Q250.63%
26 Q145.69%
25 Q444.29%
25 Q343.39%
25 Q239.63%
25 Q132.86%
24 Q413.89%
24 Q310.63%
Return on Capital
-30%-20%-10%0%10%20%24 Q425 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Return on Capital by quarter
PeriodReturn on Capital
26 Q4-14.96%
26 Q3-11.86%
26 Q2-19.98%
26 Q1-14.02%
25 Q4-25.34%
25 Q38.34%
25 Q28.61%
24 Q410.64%
Shares Outstanding
020M40M60M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q458.4M
26 Q352.84M
26 Q251.38M
26 Q151.3M
25 Q449.53M
25 Q349.53M
25 Q249.53M
25 Q149.53M
24 Q449.53M
24 Q349.53M
Book Value Per Share (USD)
-10-5051024 Q425 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q44.45
26 Q35.45
26 Q23.19
26 Q13.59
25 Q44.15
25 Q3-5.21
25 Q2-4.78
24 Q4-4.23
Total Assets (USD)
0100M200M300M400M22 Q124 Q425 Q225 Q325 Q426 Q126 Q226 Q326 Q4
KMTS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q4358.46M
26 Q3379.34M
26 Q2246.7M
26 Q1266.3M
25 Q4295.74M
25 Q3108M
25 Q2121.45M
24 Q445.95M
22 Q119.48M
Employee Count
020040060020252026
KMTS Employee Count by quarter
PeriodEmployee Count
2026443
2025330
Free Cash Flow Yield
-16%-14%-12%-10%-8%-6%med -8.85%Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
KMTS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-8.74%
Sep 26-7.82%
Aug 26-7.79%
Aug 26-7.4%
Aug 26-7.13%
Aug 26-7.56%
Jul 26-8.75%
Jul 26-9.48%
Jul 26-8.18%
Jul 26-8.73%
Jul 26-8.41%
Jun 26-8.59%
Jun 26-11.39%
Jun 26-10.89%
Jun 26-11.7%
May 26-10.68%
May 26-10.49%
May 26-11.45%
May 26-10.78%
May 26-10.4%
Apr 26-10.11%
Apr 26-9.95%
Apr 26-12.7%
Apr 26-11.44%
Mar 26-11.66%
Mar 26-11.88%
Mar 26-11.65%
Mar 26-9.65%
Feb 26-9.55%
Feb 26-8.37%
Feb 26-8.26%
Feb 26-8.73%
Jan 26-9.01%
Jan 26-9.04%
Jan 26-9.73%
Jan 26-9.1%
Jan 26-9.12%
Dec 25-8.2%
Dec 25-8.14%
Dec 25-8.5%
Dec 25-9%
Nov 25-8.03%
Nov 25-8.3%
Nov 25-8.65%
Nov 25-8.26%
Oct 25-7.91%
Oct 25-8.33%
Oct 25-8.8%
Oct 25-9.84%
Oct 25-8.72%
Sep 25-8.9%
Sep 25-8.68%
Sep 25-9.92%
Sep 25-12.02%
Aug 25-12.66%
Aug 25-11%
Aug 25-12.73%
Aug 25-14.07%
Aug 25-13.28%
Jul 25-12.34%
Jul 25-12.85%
Jul 25-12%
Jul 25-11.42%
Jun 25-10.12%
Jun 25-11.9%
Jun 25-10.16%
Jun 25-8.64%
May 25-7.94%
May 25-8.06%
May 25-7.27%
May 25-7.89%
May 25-7.53%
Apr 25-7.38%
Apr 25-7.3%
Apr 25-7.23%
Apr 25-7.54%
Mar 25-7.49%
Mar 25-7.04%
Mar 25-8.25%
Mar 25-8.36%
Price to Sales
1015202530med 16.66Apr 25Jul 25Oct 25Jan 26Mar 26Jun 26Sep 26
KMTS Price to Sales by quarter
PeriodPrice to Sales
Sep 2614.03
Sep 2615.68
Aug 2615.74
Aug 2616.57
Aug 2617.2
Aug 2616.21
Jul 2614.02
Jul 2612.93
Jul 2614.99
Jul 2616.4
Jul 2617.03
Jun 2616.68
Jun 2612.58
Jun 2613.16
Jun 2612.24
May 2613.42
May 2613.66
May 2612.51
May 2613.29
May 2613.77
Apr 2614.17
Apr 2614.4
Apr 2611.28
Apr 2612.52
Mar 2612.28
Mar 2612.06
Mar 2613.2
Mar 2615.94
Feb 2616.11
Feb 2618.38
Feb 2618.62
Feb 2617.62
Jan 2617.07
Jan 2617.02
Jan 2615.81
Jan 2616.9
Jan 2616.87
Dec 2518.77
Dec 2518.9
Dec 2518.11
Dec 2518.6
Nov 2520.85
Nov 2520.16
Nov 2519.33
Nov 2520.26
Oct 2521.15
Oct 2520.09
Oct 2519.01
Oct 2517
Oct 2519.18
Sep 2518.8
Sep 2519.27
Sep 2516.87
Sep 2514.08
Aug 2513.37
Aug 2515.39
Aug 2513.29
Aug 2512.02
Aug 2512.74
Jul 2513.71
Jul 2513.17
Jul 2514.03
Jul 2514.75
Jun 2516.63
Jun 2514.14
Jun 2516.57
Jun 2519.48
May 2521.19
May 2520.88
May 2523.16
May 2521.33
May 2522.35
Apr 2522.81
Apr 2523.06
Apr 2526.25
Apr 2525.15
Mar 2525.33
Mar 2526.96
Mar 2522.99
Mar 2522.69
Price to Book
246810med 5.77Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
KMTS Price to Book by quarter
PeriodPrice to Book
Sep 265.14
Sep 265.74
Aug 265.77
Aug 266.07
Aug 266.3
Aug 265.94
Jul 265.13
Jul 264.74
Jul 265.49
Jul 264.77
Jul 264.95
Jun 264.85
Jun 263.66
Jun 263.83
Jun 263.56
May 263.9
May 263.97
May 263.64
May 263.86
May 264
Apr 264.12
Apr 264.19
Apr 263.28
Apr 263.64
Mar 263.57
Mar 263.5
Mar 265.97
Mar 267.21
Feb 267.29
Feb 268.32
Feb 268.43
Feb 267.98
Jan 267.72
Jan 267.7
Jan 267.15
Jan 267.65
Jan 267.64
Dec 258.49
Dec 258.55
Dec 258.19
Dec 256.71
Nov 257.52
Nov 257.27
Nov 256.97
Nov 257.3
Oct 257.63
Oct 257.24
Oct 256.86
Oct 256.13
Oct 256.91
Sep 256.78
Sep 256.95
Sep 256.08
Sep 254.1
Aug 253.89
Aug 254.48
Aug 253.87
Aug 253.5
Aug 253.71
Jul 253.99
Jul 253.83
Kestra Medical Technologies, Ltd.
KMTS
Stockpicker

Video analysis: KMTS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KMTS

Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

benzinga.com · 11 Sep 2026

Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) will release its first earnings report after the closing bell on Monday, Sept.

Kestra Names Daniel Finney Vice President of Research & Development

globenewswire.com · 10 Sep 2026

Kestra Names Daniel Finney Vice President of Research & Development

KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research & Development and appointed to the company's executive leadership team.

Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for

zacks.com · 7 Sep 2026

Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for

Kestra Medical Technologies, Ltd. (KMTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

globenewswire.com · 31 Aug 2026

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14.

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

globenewswire.com · 26 Aug 2026

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE® WCD.

Here Are Monday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Apple, Dicks Sporting Goods, Domino’s Pizza, Doximity, NetApp, SanDisk, Trade Desk, and More

247wallst.com · 10 Aug 2026

Here Are Monday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Apple, Dicks Sporting Goods, Domino’s Pizza, Doximity, NetApp, SanDisk, Trade Desk, and More

Apple just got slapped with an Underperform rating while Trade Desk faces a brutal price target, but some names on Monday's analyst radar are picking up surprise upgrades that could shift the conversation entirely.

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

zacks.com · 5 Aug 2026

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Kestra Medical Technologies, Ltd. (KMTS) saw its shares surge in the last session with trading volume being higher than average.

Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

seekingalpha.com · 14 Jul 2026

Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.